Weijing Cai Selected Research

apratoxin S10

1/2019	Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model.
12/2017	Correction to "Apratoxin S10, a Dual Inhibitor of Angiogenesis and Cancer Cell Growth To Treat Highly Vascularized Tumors".
10/2017	Apratoxin S10, a Dual Inhibitor of Angiogenesis and Cancer Cell Growth To Treat Highly Vascularized Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weijing Cai Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 08/2013
16	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 08/2013
16	Inflammation (Inflammations) 10/2016 - 11/2003
12	Insulin Resistance 10/2016 - 07/2002
9	Type 2 Diabetes Mellitus (MODY) 01/2021 - 10/2002
6	Adenocarcinoma of Lung 08/2020 - 01/2017
6	Lung Neoplasms (Lung Cancer) 11/2019 - 08/2013
6	Cardiovascular Diseases (Cardiovascular Disease) 06/2010 - 03/2003
4	Chronic Disease (Chronic Diseases) 01/2021 - 06/2005
4	Cognitive Dysfunction 01/2021 - 11/2011
4	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2015
3	Chronic Renal Insufficiency 01/2020 - 05/2008
3	Diabetic Nephropathies (Diabetic Nephropathy) 12/2018 - 01/2006
3	Albuminuria 12/2018 - 01/2017
3	Disease Progression 11/2018 - 01/2012
3	Hyperglycemia 01/2018 - 06/2003
3	Kidney Diseases (Kidney Disease) 01/2017 - 08/2004
3	Renal Insufficiency (Renal Failure) 04/2008 - 03/2003
2	Adenocarcinoma 11/2023 - 11/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2022
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 01/2019
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2020 - 01/2018
2	Alzheimer Disease (Alzheimer's Disease) 05/2020 - 04/2016
2	AIDS-Associated Nephropathy (HIV-Associated Nephropathy) 12/2018 - 12/2017
2	Body Weight (Weight, Body) 10/2016 - 08/2005
2	Obesity 05/2015 - 01/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2015 - 04/2014
2	Wounds and Injuries (Trauma) 01/2014 - 11/2003
2	Hyperemia 05/2013 - 05/2008
2	Hyperplasia 10/2009 - 01/2006
2	Diabetes Complications 06/2009 - 07/2002
2	Fibrosis (Cirrhosis) 08/2008 - 04/2008
1	Thymoma (Thymic Carcinoma) 01/2023
1	Microsatellite Instability 01/2022
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2022
1	Triple Negative Breast Neoplasms 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 01/2020
1	IGA Glomerulonephritis (IGA Nephropathy) 12/2018
1	HIV Infections (HIV Infection) 12/2018
1	Lupus Nephritis 12/2018

Drug/Important Bio-Agent (IBA)

28	Advanced Glycation End ProductsIBA 01/2021 - 07/2002
14	Dietary Advanced Glycation End ProductsIBA 01/2021 - 07/2002
11	ErbB Receptors (EGF Receptor)IBA 12/2020 - 08/2013
10	Oxidants (Oxidizing Agents)IBA 04/2014 - 08/2004
8	Tyrosine Kinase InhibitorsIBA 12/2020 - 08/2013
7	Sirtuin 1IBA 01/2017 - 07/2011
6	Glucose (Dextrose)FDA LinkGeneric 12/2018 - 08/2005
4	Long Noncoding RNAIBA 01/2017 - 02/2015
4	Receptor for Advanced Glycation End ProductsIBA 10/2016 - 05/2008
4	Reactive Oxygen Species (Oxygen Radicals)IBA 09/2016 - 10/2009
4	AntioxidantsIBA 09/2016 - 11/2009
4	Pyruvaldehyde (Methylglyoxal)IBA 09/2016 - 07/2002
3	Immune Checkpoint InhibitorsIBA 11/2021 - 08/2018
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2012
3	Peptides (Polypeptides)IBA 11/2019 - 01/2018
3	apratoxin S10IBA 01/2019 - 10/2017
3	Biomarkers (Surrogate Marker)IBA 08/2018 - 08/2013
3	LipidsIBA 09/2016 - 08/2005
3	N(6)-carboxymethyllysine (carboxymethyllysine)IBA 09/2016 - 07/2002
3	Insulin (Novolin)FDA Link 01/2012 - 08/2005
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2018
2	Phosphorus (Red Phosphorus)IBA 01/2020 - 06/2012
2	VaccinesIBA 11/2019 - 08/2018
2	tyrosine receptor (receptor, tyrosine)IBA 01/2019 - 10/2017
2	Phosphotransferases (Kinase)IBA 01/2019 - 10/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017 - 01/2006
2	PlatinumIBA 01/2017 - 05/2014
2	Lactoylglutathione LyaseIBA 10/2016 - 05/2015
2	LeptinIBA 09/2016 - 05/2015
2	AdiponectinIBA 09/2016 - 05/2015
2	C-Reactive ProteinIBA 01/2006 - 06/2005
1	Lysine (L-Lysine)FDA Link 01/2023
1	extracellular matrix receptorIBA 01/2023
1	Carcinoembryonic AntigenIBA 01/2022
1	Calcibiotic Root Canal SealerIBA 01/2022
1	Keratin-19 (Keratin 19)IBA 01/2022
1	apratoxin S4IBA 01/2021
1	MineralsIBA 01/2020
1	EpitopesIBA 11/2019
1	ImmunosorbentsIBA 11/2019
1	EnzymesIBA 11/2019
1	Cancer VaccinesIBA 11/2019
1	Immunoglobulin G (IgG)IBA 11/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019
1	Anaplastic Lymphoma KinaseIBA 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Formaldehyde (Formol)FDA Link 01/2019
1	ParaffinIBA 01/2019
1	CytokinesIBA 01/2019
1	MethyltransferasesIBA 12/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2018
1	RNA (Ribonucleic Acid)IBA 12/2018
1	Decitabine FDA Link 12/2018
1	apatinibIBA 11/2018

Therapy/Procedure

9	Therapeutics 11/2023 - 10/2017
7	Drug Therapy (Chemotherapy) 01/2022 - 05/2014
2	Immunotherapy 11/2019 - 08/2018
2	Lasers (Laser) 11/2015 - 05/2013
1	Diet Therapy (Therapy, Diet) 10/2020